Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
J Immunol (1986) 136 (5): 1700–1707.
Currently there are no citedby results. Try again later.
